Meeting of the Secretary's Advisory Committee on Human Research Protections, 7481 [2010-3271]
Download as PDF
Federal Register / Vol. 75, No. 33 / Friday, February 19, 2010 / Notices
seconded by Director John E. Bowman
(Acting Director, Office of Thrift
Supervision), concurred in by Director
Thomas J. Curry (Appointive), and
Chairman Sheila C. Bair, that
Corporation business required its
consideration of the matters which were
to be the subject of this meeting on less
than seven days’ notice to the public;
that no earlier notice of the meeting was
practicable; that the public interest did
not require consideration of the matters
in a meeting open to public observation;
and that the matters could be
considered in a closed meeting by
authority of subsections (c)(2), (c)(4),
(c)(6), (c)(8), (c)(9)(A)(ii), (c)(9)(B), and
(c)(10) of the ‘‘Government in the
Sunshine Act’’ (5 U.S.C. 552b(c)(2),
(c)(4), (c)(6), (c)(8), (c)(9)(A)(ii), (c)(9)(B),
and (c)(10)). The meeting was held in
the Board Room of the FDIC Building
located at 550 - 7th Street, NW.,
Washington, DC.
Dated: February 17, 2010.
Federal Deposit Insurance Corporation.
By:
Robert E. Feldman,
Executive Secretary.
[FR Doc. 2010–3391 Filed 2–17–10; 4:15 pm]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Secretary’s Advisory
Committee on Human Research
Protections
pwalker on DSK8KYBLC1PROD with NOTICES
AGENCY: Department of Health and
Human Services, Office of the Secretary,
Office of Public Health and Science.
ACTION: Notice.
SUMMARY: Pursuant to Section 10(a) of
the Federal Advisory Committee Act,
U.S.C. Appendix 2, notice is hereby
given that the Secretary’s Advisory
Committee on Human Research
Protections (SACHRP) will hold its
twenty-second meeting. The meeting
will be open to the public.
DATE: The meeting will be held on
Tuesday, March 9, 2010 from 8:30 a.m.
until 5 p.m. and Wednesday, March 10,
2010 from 8:30 a.m. until 5 p.m.
ADDRESSES: U.S. Department of Health &
Human Services, 200 Independence
Avenue, SW., Hubert H. Humphrey
Building, Room 800, Washington, DC
20201.
FOR FURTHER INFORMATION CONTACT: Jerry
Menikoff, M.D., J.D., Director, Office for
Human Research Protections (OHRP), or
Julia Gorey, J.D., Executive Director,
SACHRP; U.S. Department of Health
VerDate Nov<24>2008
18:05 Feb 18, 2010
Jkt 220001
and Human Services, 1101 Wootton
Parkway, Suite 200, Rockville,
Maryland 20852; 240–453–8141; fax:
240–453–6909; e-mail address:
sachrp@osophs.dhhs.gov.
Under the
authority of 42 U.S.C. 217a, Section 222
of the Public Health Service Act, as
amended, SACHRP was established to
provide expert advice and
recommendations to the Secretary of
Health and Human Services and the
Assistant Secretary for Health on issues
and topics pertaining to or associated
with the protection of human research
subjects.
On March 9, 2010, OHRP staff will
provide a summary of public comments
received on two recent draft guidance
documents: Institutional Review Board
(IRB) Continuing Review of Research
and IRB Approval of Research with
Conditions. Following this presentation,
there will be a panel that will examine
the context for resolution of regulatory
harmonization issues through the
Clinical Trials Transformation Initiative
and the International Council on
Harmonization and Good Clinical
Practice. After lunch, the day will
conclude with a report from the Subpart
A Subcommittee (SAS) focusing on
issues surrounding consent for future
use of specimens or data. SAS is
charged with developing
recommendations for consideration by
SACHRP about the application of
subpart A of 45 CFR part 46 in the
current research environment. This
subcommittee was established by
SACHRP at its October 2006 meeting.
On March 10, 2010, co-chairs of the
Subcommittee on Harmonization (SOH)
will discuss the charge, initial steps,
and membership of this new group. The
SOH was established by SACHRP at its
July 2009 meeting and is charged with
identifying and prioritizing areas in
which regulations and/or guidelines for
human subjects research adopted by
various agencies or offices within HHS
would benefit from harmonization,
consistency, clarity, simplification, and/
or coordination. The remainder of
March 10 will be devoted to continuing
the previous day’s focus on the work of
the Subpart A Subcommittee. Public
comment will be heard on both days.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend the meeting and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the designated contact persons.
Members of the public will have the
opportunity to provide comments on
both days of the meeting. Public
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
7481
comment will be limited to five minutes
per speaker. Any members of the public
who wish to have printed materials
distributed to SACHRP members for this
scheduled meeting should submit
materials to the Executive Director,
SACHRP, prior to the close of business
Thursday, March 4, 2010. Information
about SACHRP and the draft meeting
agenda will be posted on the SACHRP
Web site at: https://www.hhs.gov/ohrp/
sachrp/.
Dated: February 16, 2010.
Jerry Menikoff,
Director, Office for Human Research
Protections, Executive Secretary, Secretary’s
Advisory Committee on Human Research
Protections.
[FR Doc. 2010–3271 Filed 2–18–10; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection:
Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, e-mail
paperwork@hrsa.gov or call the HRSA
Reports Clearance Office on (301) 443–
1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Proposed Project: The Health Education
Assistance Loan (HEAL) Program
Regulations (OMB No. 0915–0108)
Extension
The Health Education Assistance
Loan (HEAL) Program has regulations
that contain notification, reporting and
recordkeeping requirements to ensure
that the lenders, holders and schools
participating in the HEAL program
follow sound management procedures
in the administration of federallyinsured student loans. While the
regulatory requirements are approved
under the OMB number referenced
above, much of the burden associated
with the submission of required HEAL
forms and certain reporting
requirements is approved under
E:\FR\FM\19FEN1.SGM
19FEN1
Agencies
[Federal Register Volume 75, Number 33 (Friday, February 19, 2010)]
[Notices]
[Page 7481]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-3271]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Secretary's Advisory Committee on Human Research
Protections
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of Public Health and Science.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Pursuant to Section 10(a) of the Federal Advisory Committee
Act, U.S.C. Appendix 2, notice is hereby given that the Secretary's
Advisory Committee on Human Research Protections (SACHRP) will hold its
twenty-second meeting. The meeting will be open to the public.
DATE: The meeting will be held on Tuesday, March 9, 2010 from 8:30 a.m.
until 5 p.m. and Wednesday, March 10, 2010 from 8:30 a.m. until 5 p.m.
ADDRESSES: U.S. Department of Health & Human Services, 200 Independence
Avenue, SW., Hubert H. Humphrey Building, Room 800, Washington, DC
20201.
FOR FURTHER INFORMATION CONTACT: Jerry Menikoff, M.D., J.D., Director,
Office for Human Research Protections (OHRP), or Julia Gorey, J.D.,
Executive Director, SACHRP; U.S. Department of Health and Human
Services, 1101 Wootton Parkway, Suite 200, Rockville, Maryland 20852;
240-453-8141; fax: 240-453-6909; e-mail address:
sachrp@osophs.dhhs.gov.
SUPPLEMENTARY INFORMATION: Under the authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service Act, as amended, SACHRP was
established to provide expert advice and recommendations to the
Secretary of Health and Human Services and the Assistant Secretary for
Health on issues and topics pertaining to or associated with the
protection of human research subjects.
On March 9, 2010, OHRP staff will provide a summary of public
comments received on two recent draft guidance documents: Institutional
Review Board (IRB) Continuing Review of Research and IRB Approval of
Research with Conditions. Following this presentation, there will be a
panel that will examine the context for resolution of regulatory
harmonization issues through the Clinical Trials Transformation
Initiative and the International Council on Harmonization and Good
Clinical Practice. After lunch, the day will conclude with a report
from the Subpart A Subcommittee (SAS) focusing on issues surrounding
consent for future use of specimens or data. SAS is charged with
developing recommendations for consideration by SACHRP about the
application of subpart A of 45 CFR part 46 in the current research
environment. This subcommittee was established by SACHRP at its October
2006 meeting.
On March 10, 2010, co-chairs of the Subcommittee on Harmonization
(SOH) will discuss the charge, initial steps, and membership of this
new group. The SOH was established by SACHRP at its July 2009 meeting
and is charged with identifying and prioritizing areas in which
regulations and/or guidelines for human subjects research adopted by
various agencies or offices within HHS would benefit from
harmonization, consistency, clarity, simplification, and/or
coordination. The remainder of March 10 will be devoted to continuing
the previous day's focus on the work of the Subpart A Subcommittee.
Public comment will be heard on both days.
Public attendance at the meeting is limited to space available.
Individuals who plan to attend the meeting and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the designated contact persons. Members
of the public will have the opportunity to provide comments on both
days of the meeting. Public comment will be limited to five minutes per
speaker. Any members of the public who wish to have printed materials
distributed to SACHRP members for this scheduled meeting should submit
materials to the Executive Director, SACHRP, prior to the close of
business Thursday, March 4, 2010. Information about SACHRP and the
draft meeting agenda will be posted on the SACHRP Web site at: https://www.hhs.gov/ohrp/sachrp/.
Dated: February 16, 2010.
Jerry Menikoff,
Director, Office for Human Research Protections, Executive Secretary,
Secretary's Advisory Committee on Human Research Protections.
[FR Doc. 2010-3271 Filed 2-18-10; 8:45 am]
BILLING CODE 4150-36-P